The critical issues traditionally associated with insulin therapy in the management of diabetes become more evident during pregnancy, based on the reduced insulin sensitivity and tighter fasting and postprandial blood glucose targets to be achieved for the prevention of maternal and neonatal complications. The gene discussed is INS; the disease is diabetes mellitus.